Evaluation and management of patients with isolated neutropenia

Seminars in Hematology

Volumn 50, Issue 3, 2013, Pages 198-206

  Newburger, Peter E ^a   Dale, David C ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GRANULOCYTE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CELL COUNT; BONE MARROW EXAMINATION; BONE PAIN; CANCER RISK; CAUSAL ATTRIBUTION; CHRONIC NEUTROPENIA; CLINICAL EVALUATION; CYTOGENETICS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; ELANE GENE; G6PC3 GENE; GENE MUTATION; GENETIC SCREENING; HAX1 GENE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IDIOPATHIC DISEASE; IMMUNOASSAY; INFECTION; INFECTION CONTROL; LABORATORY TEST; LEUKOCYTE DISORDER; LEUKOCYTOSIS; LEUKOPENIA; LOW DRUG DOSE; MOUTH HYGIENE; MOUTH ULCER; MUTATOR GENE; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; SEVERE CONGENITAL NEUTROPENIA; SIDE EFFECT; TRANSIENT NEUTROPENIA;

ANIMALS; AUTOIMMUNE DISEASES; GENETIC TESTING; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE COUNT; NEUTROPENIA;

EID: 84881588821     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2013.06.010     Document Type: Article

References (46)

1. Hsieh M.M., Everhart J.E., Byrd-Holt D.D., Tisdale J.F., Rodgers G.P. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007, 146:486-492.
2. Reich D., Nalls M.A., Kao W.H., et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet 2009, 5:e1000360.
3. Dale D.C., Alling D.W., Wolff S.M. Application of time series analysis to serial blood neutrophil counts in normal individuals and patients receiving cyclophosphamide. Br J Haematol 1973, 24:57-64.
4. Dale D.C. Neutropenia and neutrophilia. Williams hematology 2010, 939-950. McGraw-Hill, New York. M.A. Lichtman, T.J. Kipps, K. Kaushansky, B. Beutler, U. Seligsohn, J.T. Prchal (Eds.).
5. Dinauer M.C., Newburger P.E. The phagocyte system and disorders of granulopoiesis and granulocyte function. Nathan & Oski's hematology of infancy and childhood 2009, 1109-1217. Saunders Elsevier, Philadelphia. S.H. Orkin, D. Ginsburg, D.G. Nathan, A.T. Look, D.A. Fisher, S.E. Lux (Eds.).
6. Husain E.H., Mullah-Ali A., Al-Sharidah S., Azab A.F., Adekile A. Infectious etiologies of transient neutropenia in previously healthy children. Pediatr Infect Dis J 2012, 31:575-577.
7. Savard M., Gosselin J. Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes. Virus Res 2006, 119:134-145.
8. Sloand E. Hematologic complications of HIV infection. AIDS Rev 2005, 7:187-196.
9. Dale D.C., Wolff S.M. Studies of the neutropenia of acute malaria. Blood 1973, 41:197-206.
10. Olliaro P., Djimde A., Dorsey G., et al. Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Am J Trop Med Hyg 2011, 85:619-625.
11. Dale D.C., Bolyard A.A., Schwinzer B.G., et al. The Severe Chronic Neutropenia International Registry: 10-year follow-up report. Support Cancer Ther 2006, 3:220-231.
12. Bux J. Human neutrophil alloantigens. Vox Sang 2008, 94:277-285.
13. Clay M.E., Schuller R.M., Bachowski G.J. Granulocyte serology: current concepts and clinical signifcance. Immunohematology 2010, 26:11-21.
14. Bruin M., Dassen A., Pajkrt D., et al. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang 2005, 88:52-59.
15. Bux J., Behre G., Jaeger G., Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998, 91:181-186.
16. Kwon S.W., Procter J., Dale J.K., Straus S.E., Stroncek D.F. Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang 2003, 85:307-312.
17. Podjasek J.C., Abraham R.S. Autoimmune cytopenias in common variable immunodeficiency. Front Immunol 2012, 3:189.
18. Fung Y.L., Silliman C.C. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev 2009, 23:266-283.
19. Mohan S.R., Maciejewski J.P. Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia. Curr Opin Hematol 2009, 16:27-34.
20. Lamy T., Loughran T.P. How I treat LGL leukemia. Blood 2011, 117:2764-2774.
21. Klein C. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu Rev Immunol 2011, 29:399-413.
22. Boxer L.A., Newburger P.E. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 2007, 49:609-614.
23. Dale D.C. ELANE-related neutropenia. In: Pagon R.A., Bird T.D., Dolan C.R., Stephens K., Adams M.P., eds. GeneReviews. Accessed November 24, 2012. http://www.ncbi.nlm.nih.gov/books/NBK1533/.
24. Dale D.C., Person R.E., Bolyard A.A., et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000, 96:2317-2322.
25. Grenda D.S., Murakami M., Ghatak J., et al. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood 2007, 110:4179-4187.
26. Kollner I., Sodeik B., Schreek S., et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 2006, 108:493-500.
27. Newburger P.E., Pindyck T.N., Zhu Z., et al. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer 2010, 55:314-317.
28. Klein C., Grudzien M., Appaswamy G., et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2006, 39:86-92.
29. Boztug K., Appaswamy G., Ashikov A., et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 2009, 360:32-43.
30. Boztug K., Rosenberg P.S., Dorda M., et al. Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr 2012, 160:679-683.
31. Germeshausen M., Grudzien M., Zeidler C., et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 2008, 111:4954-4957.
32. Ancliff P.J., Blundell M.P., Cory G.O., et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood 2006, 108:2182-2189.
33. Xia J., Bolyard A.A., Rodger E., et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol 2009, 147:535-542.
34. Guerry D., Dale D.C., Omine M., Perry S., Wolff S.M. Periodic hematopoiesis in human cyclic neutropenia. J Clin Invest 1973, 52:3220-3230.
35. Beekman R., Valkhof M.G., Sanders M.A., et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012, 119:5071-5077.
36. Skokowa J., Steinemann D., Makaryan V., et al. RUNX1 mutations are the most frequent leukemia associated mutations in congenital neutropenia patients. ASH Annual Meeting Abstracts 2012, 120:7.
37. de Alarcon P.A., Goldberg J., Nelson D.A., Stockman J.A. Chronic neutropenia: diagnostic approach and prognosis. Am J Pediatr Hematol Oncol 1983, 5:3-9.
38. Boxer L.A., Bolyard A.A., Schwinzer B., et al. Antineutrophil antibodies lead to mistaken identity in severe congenital neutropenia [abstract]. Blood (ASH Annual Meeting Abstracts) 2005, 106:385.
39. Riera N.E., Rosso S.M., Galan V., et al. Anti-polymorphonuclear neutrophil antibodies in patients with leukopenia or neutropenia. Int J Lab Hematol 2010, 32:e96-105.
40. Muschter S., Berthold T., Greinacher A. Developments in the definition and clinical impact of human neutrophil antigens. Curr Opin Hematol 2011, 18:452-460.
41. Dale D.C., Bonilla M.A., Davis M.W., et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993, 81:2496-2502.
42. Rosenberg P.S., Zeidler C., Bolyard A.A., et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010, 150:196-199.
43. Rosenberg P.S., Alter B.P., Bolyard A.A., et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107:4628-4635.
44. Makaryan V., Zeidler C., Bolyard A.A., et al. Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, ELANE. ASH Annual Meeting Abstracts 2012, 120:3275.
45. Beaupain B., Leblanc T., Reman O., et al. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry. Pediatr Blood Cancer 2009, 53:1068-1073.
46. Fioredda F., Calvillo M., Lanciotti M., et al. Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer 2010, 54:465-467.